Clinical Burden of Post-ablation Atrial Fibrillation Recurrence in East Asia: A Systematic Literature Review
Arrhythmia & Electrophysiology Review · 20.07.2026
DOI: 10.15420/aer.2025.64 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Arrhythmia & Electrophysiology Review, online erschienen am 20.07.2026. Verfasst von Jie Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Xiangya Hospital, Central South University Changsha, China. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Aim
This study aimed to systematically review and synthesise existing real-world evidence on the clinical characteristics and outcomes of patients with post-ablation AF recurrence in east Asia.
Methods
Following the PRISMA guidelines, main Chinese- and English-language databases were searched for observational studies published from 2019 to 2024. Inclusion criteria targeted East Asian patients aged ≥18 years with post-ablation AF recurrence. Two independent reviewers conducted study selection, data extraction and quality assessment using the Newcastle–Ottawa Scale. Meta-analyses were performed using a random effects model to synthesise the extracted data.
Results
A total of 68 studies involving 28,750 patients were included. Paroxysmal AF accounted for about half of the population (53.4%; 95% CI [47.8–58.9]). Common comorbidities included hypertension (52.6%; 95% CI [50.2–55.0]), coronary artery disease (17.2%; 95% CI [12.9–22.5]) and diabetes (16.8%; 95% CI [14.9–18.8]). The AF recurrence rates after repeat ablation (21.4%; 95% CI [16.6–27.1]) and antiarrhythmic drug therapy (19.6%; 95% CI [18.0–21.2]) were similar. Recurrence was higher in patients with late recurrence (32.6%; 95% CI [26.9–38.8]) than those with early recurrence (21.5%; 95% CI [17.9–25.6]). The pooled 3-year incidence of major events included heart failure hospitalisation (3.2%; 95% CI [2.8–3.6]), ischaemic stroke (1.2%; 95% CI [0.9–1.7]) and cardiovascular-related death (0.3%; 95% CI [0.1–0.5]).
Conclusion
Post-ablation AF recurrence in East Asia imposes a considerable disease burden with high recurrence rates even after repeated ablation or antiarrhythmic drug therapy. The presence of prevalent comorbidities and measurable risks of morbidity and mortality further contribute to the long-term clinical and economic burdens of AF.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Xiangya Hospital, Central South University Changsha, China.
- Department of Critical Care Medicine, Xiangya Hospital, Central South University Changsha, China.
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University Changsha, China.
- Changsha Normin Health Technology Changsha, China.
- Normin Health Consulting Mississauga, Canada.
ORCID-Profile: Jie Liu, Hao Liu, Dan Yu, Tingyin Chen, Zhaoxin Qian, Yuting Chen, Wendong Chen, Ruizheng Shi
Zitieren
APA
Liu, J., Liu, H., Yu, D., Chen, T., Qian, Z., Chen, Y., Chen, W., & Shi, R. (2026). Clinical Burden of Post-ablation Atrial Fibrillation Recurrence in East Asia: A Systematic Literature Review. Arrhythmia & Electrophysiology Review. https://doi.org/10.15420/aer.2025.64
Vancouver
Liu J, Liu H, Yu D, Chen T, Qian Z, Chen Y, et al. Clinical Burden of Post-ablation Atrial Fibrillation Recurrence in East Asia: A Systematic Literature Review. Arrhythmia & Electrophysiology Review. 2026. doi:10.15420/aer.2025.64
BibTeX
@article{Liu2026,
author = {Liu, Jie and Liu, Hao and Yu, Dan and Chen, Tingyin and Qian, Zhaoxin and Chen, Yuting and Chen, Wendong and Shi, Ruizheng},
title = {Clinical Burden of Post-ablation Atrial Fibrillation Recurrence in East Asia: A Systematic Literature Review},
journal = {Arrhythmia & Electrophysiology Review},
year = {2026},
doi = {10.15420/aer.2025.64}
}
EUVIMED